On orphan uniqueness to standard technology
The paper discusses the problem of free drug provision as an integral part of medical care in the amount of state guarantees and lists legislative contradictions that cause the above violation. It clarifies the concept of the drug legal status, by using examples, and on this basis considers whether...
Main Author: | A V Saverskiĭ |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2014-12-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31625 |
Similar Items
-
FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development
by: Kathleen L. Miller, et al.
Published: (2020-09-01) -
Principles of Compulsory Medical Insurance: some law enforcement issues
by: Sokolova N. A., et al.
Published: (2012-05-01) -
The problem of rare (orphan) diseases in the Russian Federation: Medical and normative legal aspects of its solution
by: P V Novikov
Published: (2014-12-01) -
THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE
by: Yu. A. Ledovskikh, et al.
Published: (2018-02-01) -
ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION
by: M. V. Sura, et al.
Published: (2015-03-01)